SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language
International | eng
Country Language

Fortify Assura

Implantable Cardioverter Defibrillator

Technology

Technology

Unique Features: Shockguard Technology

For protection against inappropriate and unnecessary shocks, our Fortify Assura™ ICD utilizes expanded ShockGuard™ technology.

  • Approximately one-third of all ICD shocks are inappropriate.1
  • Reducing shocks correlates with increased quality of life.2
  • DecisionTx™ programming allows for better discrimination of arrhythmias, resulting in the most appropriate therapy for the patient.
  • Far Field MD™ morphology discrimination algorithm improves upon the use of near-field morphology analysis alone, further reducing inappropriate therapies.
  • Chamber Onset discrimination algorithm utilizes both atrial and ventricular interval information for rhythm diagnosis, determining which chamber is driving the arrhythmia.
  • SecureSense™ RV lead noise discrimination algorithm (Non-sustained SecureSense™ episodes) differentiates lead noise from true ventricular tachycardia (VT)/ventricular fibrillation (VF) episodes, providing the ability to automatically withhold tachycardia therapy in the presence of lead noise.

Patient Safety Enhancements

DynamicTx Over-current Detection Algorithm

DynamicTx™ over-current detection algorithm feature provides the opportunity for devices to deliver a shock, and possibly terminate a VT/VF episode, even in the presence of a compromised lead.

  • Checks for compromised vector integrity
  • Attempts to find a viable configuration to deliver high voltage therapy, while avoiding a problematic vector

 

TailoredTherapy Features

Our exclusive, customizable TailoredTherapy™ features allow you to individually adjust programming to meet the unique needs of each patient, delivering precise therapy for each patient, every time. These innovative features include:

  • DeFT Response™ technology
  • Complete capture confirmation
  • Automatic pacing outputs, periodically measured and adjusted, for optimal therapy delivery in every chamber of the heart

 

Building Comprehensive Cardiac Arrhythmia Management

The Fortify Assura ICD is part of our cardiac arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-saving technologies that improve therapy outcomes.

Manuals & Resources

Cardiovascular Products

Customer Service

References

  1. Daubert, J. P., Zareba, W., Cannom, D. S., McNitt, S., Rosero, S. Z., Wang, P., … Moss, A. J., & MADIT II Investigators. (2008). Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. Journal of the American College of Cardiology, 51(14), 1357 1365. https://dx.doi.org/10.1016/j.jacc.2007.09.073
  2. Sears, S. F., & Conti, J. B. (2002). Quality of life and psychological functioning of ICD patients. Heart, 87(5) , 488-493. https://dx.doi.org/10.1136/heart.87.5.488
  3. Data on file, bench testing data doc 60045162.
  4. Data on file, bench testing data doc 60045369.

MAT-2205118 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2023 Abbott. All Rights Reserved.

MAT-2001111 v5.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

MAT-2305078 v1.0